These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 201838)

  • 21. Nephrolithiasis.
    Melick R
    Aust N Z J Med; 1979 Dec; 9(6):718-21. PubMed ID: 294932
    [No Abstract]   [Full Text] [Related]  

  • 22. Rational therapy of nephrolithiasis, Part I.
    Pak CY
    Ration Drug Ther; 1984 Nov; 18(11):1-6. PubMed ID: 6536977
    [No Abstract]   [Full Text] [Related]  

  • 23. Hyperuricosuric calcium oxalate nephrolithiasis.
    Coe FL
    Kidney Int; 1978 May; 13(5):418-26. PubMed ID: 661071
    [No Abstract]   [Full Text] [Related]  

  • 24. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E
    Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of calcium urolithiasis in ambulatory patients: comparison of results with those of inpatient evaluation.
    Pak CY; Fetner C; Townsend J; Brinkley L; Northcutt C; Barilla DE; Kadesky M; Peters P
    Am J Med; 1978 Jun; 64(6):979-87. PubMed ID: 207183
    [No Abstract]   [Full Text] [Related]  

  • 26. Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers.
    Robertson WG; Peacock M
    Clin Sci; 1972 Oct; 43(4):499-506. PubMed ID: 4653589
    [No Abstract]   [Full Text] [Related]  

  • 27. [Whewellite and weddellite: toward a different etiopathogenesis. The significance of morphological typing of calculi].
    Daudon M; Réveillaud RJ
    Nephrologie; 1984; 5(5):195-201. PubMed ID: 6531056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A retrospective analysis of the metabolic status of stone formers in the New York City metropolitan areas.
    Hatch M; Schepers A; Grunberger I; Godec CJ
    N Y State J Med; 1991 May; 91(5):196-200. PubMed ID: 1857571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The urinary calcium-magnesium ratio in calcigerous stone formers.
    King JS; O'Connor FJ; Smith MJ; Crouse L
    Invest Urol; 1968 Jul; 6(1):60-5. PubMed ID: 5663560
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacologic treatment of calcium calculi.
    Preminger GM
    Urol Clin North Am; 1987 May; 14(2):325-33. PubMed ID: 3576853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of medical treatment of renal lithiasis 5 years later].
    Ruiz Marcellán FJ; Bernshtam J; Pinto B
    Actas Urol Esp; 1982; 6(5):273-6. PubMed ID: 7158456
    [No Abstract]   [Full Text] [Related]  

  • 33. Acclerated calcium nephrolithiasis.
    Coe FL; Parks JH; Strauss AL
    JAMA; 1980 Aug 22-29; 244(8):809-10. PubMed ID: 7392192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urine oxalate and calcium in idiopathic renal stone formers.
    Wallace MR; Mason K; Gray J
    N Z Med J; 1981 Aug; 94(689):87-9. PubMed ID: 6944647
    [No Abstract]   [Full Text] [Related]  

  • 35. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary cAMP excretion in gouty patients with and without nephrolithiasis.
    Carcassi A; Galli M; Boschi S; Di Cairano G
    Adv Exp Med Biol; 1984; 165 Pt A():145-9. PubMed ID: 6326478
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():171-7. PubMed ID: 6937993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The prevention of recurrence of calculus: results of a regional study].
    Labeeuw M; Pozet N; Martin X; Lareal MC
    Nephrologie; 1989; 10(4):205-7. PubMed ID: 2633068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diurnal variations in calcium phosphate and calcium oxalate activity products in normal and stone-forming urines.
    Hodgkinson A; Marshall RW; Cochran M
    Isr J Med Sci; 1971 Nov; 7(11):1230-4. PubMed ID: 5159604
    [No Abstract]   [Full Text] [Related]  

  • 40. Practical aspects of the handling of samples and evaluation of laboratory data.
    Tiselius HG
    Scand J Urol Nephrol Suppl; 1980; 53():105-8. PubMed ID: 6937986
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.